BioCentury
ARTICLE | Financial News

Cytos completes rights offering

May 21, 2012 7:00 AM UTC

Cytos Biotechnology AG (SIX: CYTN), Schlieren, Switzerland Business: Neurology, Inflammation, Cardiovascular Date completed: 5/10/12 Type: Rights offering Raised: CHF3.2 million ($3.4 million) Shares:...